Acumen Pharmaceuticals, Inc. (ABOS) vs Compass Therapeutics, Inc. (CMPX)
A side-by-side comparison of Acumen Pharmaceuticals, Inc. and Compass Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ABOS
Acumen Pharmaceuticals, Inc.
$2.13HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
CMPX
Compass Therapeutics, Inc.
$0.96HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — ABOS vs CMPX
growth of $100 · dividends reinvested · last 5yABOS -89.4% (-36.2%/yr)CMPX -80.4% (-27.8%/yr)CMPX compounded faster over this window
ABOS CMPX
ABOS vs CMPX: by the numbers
- •CMPX is the larger company ($173M vs $154M market cap).
Metrics side by side
Valuation
| Metric | ABOS | CMPX |
|---|---|---|
| P/B ratio | 2.69 | 1.04 |
Profitability
| Metric | ABOS | CMPX |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -183.44% | -44.23% |
| ROIC | -118.67% | -46.59% |
Growth (annualized)
| Metric | ABOS | CMPX |
|---|---|---|
| Total return CAGR (5Y) | -32.60% | -22.79% |
Frequently asked
- How have ABOS and CMPX total returns compared?
- Over the past 5 years, ABOS delivered -32.60% and CMPX delivered -22.79% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.